BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4242418)

  • 1. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
    Lorenz D; Dell HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the effect of coronary dilators on the coronary blood circulation in man].
    Hilger HH; Behrenbeck DW; Hellwig H; Wagner J
    Arzneimittelforschung; 1970 Mar; 20():441-2. PubMed ID: 5468726
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the mechanism of action of coronary dilators].
    Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return.
    Holtermann W; Lochner W
    Arzneimittelforschung; 1972 Aug; 22(8):1376-81. PubMed ID: 4629177
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
    Winbury MM; Howe BB; Hefner MA
    J Pharmacol Exp Ther; 1969 Jul; 168(1):70-95. PubMed ID: 4978326
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental test of the action of coronary dilators in humans].
    Hilger HH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):168-84. PubMed ID: 4896196
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O; Grossmann W; Stühlinger W; Raberger G
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effect of a coronary vasodilator].
    Nakamura Y; Nagoshi H; Takei F; Takahashi M; Matsumura N
    Kokyu To Junkan; 1972 Sep; 20(9):805-9. PubMed ID: 4676839
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of 4-[5-amino-3-(4-pyridyl)-1-pyrazolyl] -1-methyl-piperidine hydrochloride upon the general and coronary hemodynamics of the intact animal.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):373-8. PubMed ID: 5954036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 19. [The coronary dilatator effect of various reference drugs].
    Duchene-Marullaz P; Cosnier D; Grimald J
    Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Promotion of organ circulation by raubasine].
    Dietmann K
    Arzneimittelforschung; 1967 Aug; 17(8):969-75. PubMed ID: 5632071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.